Investing in Innovation (i3), a pan-African support initiative for African health supply chain start-ups, has announced its first cohort of 30 start-ups from 14 countries in Africa, as efforts to jump-start a new way of doing business and support African-led innovations in health.
Selected start-ups will receive a $50,000 grant and support to catalyse growth-driven partnerships with donors, industry and institutions.
The selected companies are: Chekkit Technologies, Disrupt Pharma Tech Africa (Medsaf), DrugStoc Ehub Limited, Erith Health Services, Gricd, LifeBank, Lifestores Healthcare, OneHealth, ClinicPesa, Damu Sasa, The Pathology Network, Negus Med and Signalytic.
Others are; Viebeg Technologies, Zuri Health, Xetova, Cure Bionics, DeepEcho, Dr Sett, Infiuss Health Limited, Medevice, Meditect, Sobrus, Valorigo, Azanza Health, Appy Saude, Aviro Health, Contro, VaxiGlobal, Zinacare.
Funded by the Bill & Melinda Gates Foundation and sponsored by Merck Sharp & Dohme (MSD), the World Health Organization Regional Office for Africa, AUDA-NEPAD, and AmerisourceBergen, i3 unites leading donors, industry and African institutions to jump-start a new way of doing business to support African-led innovations in health.
The 30 companies selected hail from 14 African countries. Operating in early- and growth-stages, the companies are delivering novel solutions for device and medicines distribution, stock management and financing, authentication, traceability, medical waste management and more, demonstrating that African-built solutions are poised to help transform access to health products in many ways.